Vaccines Archives - Infectious Disease Advisor

Diphtheria, tetanus, and pertussis are serious diseases caused by bacteria. Diphtheria and pertussis are spread from person to person. Tetanus enters the body through cuts or wounds. Patients should receive five doses of DTaP vaccine at 2 months, 4 months, 6 months, 15 to 18 months, and 4 to 6 years.

Vaccine-Related Viral Shedding Leads to High Rate of Rotavirus Overdiagnosis

By

Infectious Disease Advisor Contributing Writer

January 24, 2020

Over a 2-year period, roughly half of positive cases of rotavirus in infants were the result of vaccine-related viral shedding.

Influenza

Enhanced Influenza Vaccines Offer Improved Antibody Response in Older Adults

By

Sweta Gupta

January 24, 2020

Compared with a standard-dose influenza vaccine, several enhanced influenza vaccines improved humoral and cell-mediated immune responses in older adults.

The HPV vaccine protects against the human papillomaviruess and causes most cervical cancers. It is recommended for male and female patients aged 11 to 12 years. Stressing the importance of the vaccine to boys, especially, can help reduce spread of the disease. The vaccine can be administered to female patients aged 26 and under and male patients aged 21 years and younger.

Practice Management

HPV Vaccine Program Recovery Difficult After Public Scares

January 21, 2020

Misinformation in the Danish media between 2013 and 2016 led to a 50.4 percent drop in human papillomavirus vaccinations among girls in Denmark.

Prevention

Mandatory Vaccination Increases Prevalence of Vaccine Coverage

January 17, 2020

Mandatory vaccination is associated with increased vaccination coverage for measles and pertussis as well as reduced measles incidence in Europe.

Influenza

Influenza Vaccine for Older Adults Granted Fast Track Status

By

Steve Duffy

January 17, 2020

The Food and Drug Administration has granted Fast Track designation to NanoFlu (Novavax) for seasonal influenza vaccination in adults ≥65 years.

Prevention

Microbiologic Failure in the Setting of Clinical Cure of Bacterial Pneumonia

By

Bradley van Paridon

January 16, 2020

Microbiologic treatment failure was found to be independently associated with recurrent pneumonia or death among patients with bacterial pneumonia after clinical cure.

Respiratory

Investigational RSV Vaccine Gets Fast Track Status

By

Diana Ernst, RPh

January 15, 2020

An investigational vaccine to protect against respiratory syncytial virus infection has received Fast Track designation from the FDA.

Prevention

Updated Recommendations on the Use of Anthrax Vaccine in the United States

By

Bradley van Paridon

January 14, 2020

The CDC’s Prevention’s Advisory Committee on Immunization Practices updated recommendations regarding the use of anthrax vaccine in the US.

HIV/AIDS

Patients With HIV Lose Immunity to Smallpox Despite Vaccination

January 14, 2020

HIV-infected patients lose immunity to smallpox despite childhood vaccination and immune reconstitution with antiretroviral therapy.

Prevention

CDC Reports Increasing Rate of Adults Who Received HPV Vaccine

January 9, 2020

From 2013 to 2018, there was an increase in the percentage of adults aged 18 to 26 years who received one or more doses or the recommended number of doses of HPV vaccine.